Antiplatelet activity of hydralazine.
D000244:Adenosine Diphosphate / Q000494:pharmacology; D000818:Animals; D001095:Arachidonic Acids / Q000378:metabolism; D001792:Blood Platelets / Q000187:drug effects*; D002118:Calcium / Q000378:metabolism; D000242:Cyclic AMP / Q000378:metabolism; D004305:Dose-Response Relationship, Drug; D006801:Humans; D006830:Hydralazine / Q000494:pharmacology*; D008297:Male; D010974:Platelet Aggregation / Q000187:drug effects; D051381:Rats; D013931:Thromboxanes / Q000096:biosynthesis
D001095:Arachidonic Acids; D013931:Thromboxanes; D006830:Hydralazine; D000244:Adenosine Diphosphate; D000242:Cyclic AMP; D002118:Calcium